Training

Register now

Virtual meeting

Via Zoom

Description

This training will cover evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention will be directed towards effective measures that support the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.

NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which will not count for credit. 

Intended audience

Medical providers, nurses, social workers, Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), recovery coaches, counselors, Licensed Mental health Counselors (LMHC), and others working in addiction medicine.

Speakers

Andrea Jodat, DNP, FNP-BC, CARN-AP (she/her)

Andrea is a clinical nurse educator for Boston Medical Center's Grayken Center for Addiction Training and Technical Assistance, where she contributes to the development and delivery of continuing education programs, peer-reviewed publications, evidence-based clinical guidelines, and other resources for providers supporting patients with substance use disorders. She is also a family nurse practitioner at Boston Medical Center, an assistant professor of medicine at the Boston University Chobanian & Avedisian School of Medicine, and conducts research in the use of telehealth and coordinated care for persons with opioid use disorder and depression. Andrea is an active member of the Boston University Medical Group Advanced Practice Provider Council and the Massachusetts Coalition of Nurse Practitioners. Andrea has worked with vulnerable populations for over 10 years including managing substance use disorders and overall healthcare for persons experiencing homelessness with the Boston Health Care for the Homeless Program. She is a term lecturer and preceptor for nurse practitioner students at the Massachusetts General Hospital Institute of Health Professions (IHP) and received her Doctor in Nursing Practice (DNP) degree from the IHP in 2018. She also holds certification as a Certified Addiction Registered Nurse - Advanced Practice (CARN-AP) through the Addictions Nursing Certification Board (ANCB).

Annie Potter, MSN, MPH, NP (she/her)

Annie is a clinical nurse educator for Boston Medical Center's Grayken Center for Addiction Training and Technical Assistance, an assistant professor of medicine at Boston University Chobanian & Avedisian School of Medicine, and a nurse practitioner at Boston Medical Center. Annie contributes to peer-reviewed publications, evidence-based clinical guidelines, development and delivery of continuing education programs, and other resources for clinicians supporting patients with substance use disorders. Annie is also consultant and educator for the Massachusetts HEALing Communities Study, a multi-state study funded by the National Institute on Drug Abuse. She is also the Medical Director for the Massachusetts Community Health Center ECHO and an expert faculty member of the Provider Clinical Support System Exchange (PCSS-X). Annie's other clinical interests include treatment and prevention of HIV and Hepatitis C, family planning, and care for gender-diverse individuals. Before joining Boston Medical Center, Annie practiced at a community health center in Baltimore, MD, where she established and directed the city's first walk-in HIV treatment and prevention program. She is board-certified in addictions and holds specialty certifications for the treatment of HIV and Hepatitis C. Annie earned both her Master of Nursing and Master of Public Health from Johns Hopkins University.

Objectives

At the end of this training, participants will have the knowledge necessary to:

• Describe the prevalence of illicitly manufactured fentanyl in the US drug supply.
• Explain the major pharmacologic properties of both fentanyl and buprenorphine.
• Recall at least two “tools” that can help guide the process of starting buprenorphine treatment.
• Identify at least three medications that have been proven to support management of withdrawal symptoms during the buprenorphine initiation process.

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

REQUIREMENTS for credit

1. Register for training
2. Arrive/log into the training no more than 10 minutes after designated start time for program.
3. Identify yourself by typing your full name into the chat and ensuring your zoom name matches that used to register for training (or you cannot be marked on attendance).
4. Be present through the end of the activity (i.e. until the designated end time of training).
5. Complete evaluation within 2 weeks of program completion.

Please note this policy is strictly enforced for accreditation purposes. Participants will forfeit collection of credit and certificates of completion if more than 10 minutes of the training is missed.

CME

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing

Boston Medical Center is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Participants who complete and return the evaluation and stay for the entire session will be awarded 1.00 contact hour(s), with 1.00 contact hour(s) classified as pharmacology.

Social Work

As a Jointly Accredited Organization, Boston University Chobanian & Avedisian School of Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 general continuing education credits.

LMHC

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 1.00 contact hours will be offered to participants who attend the training and complete the evaluation.

LADC/CADC & Recovery Coach

Grayken Center for Addiction TTA is approved to offer LADC/CADCs and recovery coaches who complete this course 1.00 general continuing education credits.

Disclaimer

Continuing education (CE) requirements vary by license and jurisdiction. When requesting continuing education credits, please ensure you are following the rules and regulations determined by the board regulating your license. Boston Medical Center Grayken Center for Addiction TTA does not oversee adherence to licensing requirements and regulations. 

Register now